Addressing Non-Compliance in QA Tests for Multi-Layer Tablets
In the pharmaceutical industry, multi-layer tablets have emerged as a preferred solid dosage form due to their ability to deliver multiple active pharmaceutical ingredients (APIs) in a single dose and to provide controlled release of medications. However, ensuring the quality and compliance of these complex formulations poses unique challenges. Quality assurance (QA) tests are crucial in verifying that multi-layer tablets meet the necessary standards for safety, efficacy, and quality. This article provides a comprehensive guide to addressing non-compliance issues in QA tests for multi-layer tablets, exploring common challenges and offering solutions grounded in regulatory guidelines.
Click to read the full article.